![](/img/cover-not-exists.png)
PND38 10-YEAR COST-EFFECTIVENESS ANALYSES OF FREMANEZUMAB COMPARED TO ERENUMAB AS PREVENTIVE TREATMENT IN EPISODIC MIGRAINE FOR PATIENTS WITH INADEQUATE RESPONSE TO PRIOR PREVENTIVE TREATMENTS
Smolen, L., Cohen, J., Klein, T., Gandhi, S.K., Thompson, S.Volume:
22
Journal:
Value in Health
DOI:
10.1016/j.jval.2019.09.1808
Date:
November, 2019
File:
PDF, 319 KB
2019